Global Artificial Intelligence In Cardiology Market

Artificial Intelligence In Cardiology Market Summary

The Global Artificial Intelligence In Cardiology Market Size Was Estimated at USD 1.17 Billion in 2024 and is Projected to Reach USD 11.30 Billion by 2035, Growing at a CAGR of 22.9% from 2025 to 2035. The market for AI in cardiology is expanding because of the rising prevalence of cardiovascular diseases worldwide, the need for early detection and individualized care, the abundance of data from wearable technology and electronic medical records, and AI's capacity to increase diagnostic precision, optimize workflows, and lessen clinician burnout.

Key Regional and Segment-Wise Insights

• In 2024, North America held the greatest revenue share of 44.37% in the AI in cardiology market.
• In 2024, the hardware segment held the biggest revenue share of 35.28%, leading the market by component.
• In 2024, the diagnosis segment dominated the market by application, with the biggest revenue share of 38.42%.

Global Market Forecast and Revenue Outlook

• 2024 Market Size: USD 1.17 Billion
• 2035 Projected Market Size: USD 11.30 Billion
• CAGR (2025-2035): 22.9%
• North America: Largest market in 2024

The Artificial Intelligence (AI) in Cardiology Market encompasses the deployment of AI technologies for cardiovascular disorder diagnosis and management through machine learning and deep learning, and data analytics. The worldwide increase in heart conditions, including arrhythmias and heart failure, and coronary artery disease, is propelling this market toward rapid expansion.  Market growth results from the expanding requirement of precise early diagnosis, together with efforts to reduce healthcare expenses while improving patient outcomes. The market expansion stems mainly from the rising adoption of digital health solutions, together with EHR big data availability and healthcare provider recognition of AI benefits.

The advancement of AI in the cardiology market relies primarily on emerging technological breakthroughs. The field of cardiovascular care receives transformation through cutting-edge wearable devices that deliver instant monitoring alongside risk evaluation systems powered by predictive algorithms and artificial intelligence-based image analysis tools. Remote diagnosis and patient management are enhanced through telemedicine platform integration. Governments along with regulatory agencies across the world, push for AI adoption through funding programs and research support, as well as ethical frameworks dedicated to healthcare AI. The worldwide adoption of AI in cardiology continues to accelerate because of these initiatives that create advanced diagnostic methods and customized treatment plans, as well as better overall cardiovascular management.

Component Insights

The hardware segment led the artificial intelligence in cardiology market with the largest revenue share of 35.28% in 2024. The dominance of this market segment arises from rising requirements for advanced imaging devices and diagnostic equipment, together with wearable health tracking systems that incorporate artificial intelligence capabilities. Real-time data collection, together with processing functions in hardware components, enables precise cardiovascular disease diagnosis and monitoring. The growth trajectory receives additional momentum from medical settings that adopt high-performance computing systems, portable cardiac devices, and AI-powered ECG machines.  The market segment maintains its leading position because healthcare infrastructure investments increase and diagnostic tool accuracy requirements grow.

During the forecast period, the software segment of the artificial intelligence in cardiology market is anticipated to grow at the fastest CAGR. The expansion results from increasing adoption of AI-powered software that performs data analysis alongside predictive modeling and clinical decision support functions. Software technologies allow physicians to develop personalized treatment plans as well as automate medical image interpretation and identify heart conditions at early stages. The expansion of cloud-based platforms combined with electronic health records (EHRs) creates better real-time data sharing opportunities and improved accessibility for healthcare providers. The continuous development of machine learning algorithms and AI analytics brings higher precision and better diagnostic outcomes. 

Application Insights

The diagnosis segment led the artificial intelligence in cardiology market with the largest revenue share of 38.42% in 2024. AI technology surpasses other diagnostic tools because it delivers quick and precise cardiovascular problem recognition, which establishes its market dominance. AI-powered tools transform diagnostic processes by analyzing medical imaging along with ECGs and patient data to detect diseases such as arrhythmias, heart failure, and coronary artery disease at early stages. Heart disorders are rising globally, and medical professionals require non-invasive early diagnostics, which has accelerated AI adoption across this domain. The growing adoption of sophisticated imaging systems combined with decision-support software allows healthcare practitioners to make faster data-based diagnostic decisions, which drives segment growth.

The prediction segment of artificial intelligence in the cardiology market will experience the fastest CAGR during the forecast period. AI prediction models detect cardiovascular disease risks at early stages, which drives the market expansion due to increasing demand for preventive cardiac care. Through the evaluation of extensive patient data, which includes genetic information along with lifestyle choices and medical background, AI systems demonstrate precise capabilities to foresee cardiac events, including heart attacks and strokes.  The implementation of predictive analytics within clinical workflows enables healthcare professionals to deliver early treatments, which leads to better patient results and reduced hospital admissions. Machine learning advancements alongside real-time data processing enhance the accuracy and practical applications of AI in predicting cardiac risks.

Regional Insights

North America dominated the artificial intelligence in cardiology market with the largest revenue share of 44.37% during 2024. The advanced healthcare infrastructure and extensive digital health platform implementation, combined with major AI medical device firms operating in this region, support its market dominance. The United States leads the rapid adoption of artificial intelligence in cardiology through its use for patient monitoring, predictive analytics, and diagnostic applications.  Healthcare facilities embrace artificial intelligence more strongly because governments provide useful support and invest heavily in research and development, while regulatory bodies maintain appropriate frameworks. North America continues to lead the cardiology artificial intelligence market because medical professionals better understand AI benefits for treatment outcomes, while cardiovascular disorder rates keep increasing.

Europe AI in Cardiology Market Trends

The artificial intelligence in cardiology market continues to expand throughout Europe because of increasing cardiovascular disease cases, healthcare digitization, and government AI healthcare promotion. The healthcare sector in Germany, the UK, and France actively integrates modern diagnostic monitoring systems with AI solutions and actively invests in AI-based research. The European Union funds healthcare innovation through Horizon Europe as well as regulatory initiatives to advance artificial intelligence applications. AI treatments for cardiology progress rapidly due to growing collaborations between technology providers and medical institutions. The market continues its upward trend because of positive industry conditions, precise patient assessments, and early medical intervention.

Asia Pacific AI in Cardiology Market Trends

The Artificial Intelligence in Cardiology market in the Asia Pacific is expected to grow at a significant rate because of increasing cardiovascular disease rates, together with growing healthcare understanding and quick adoption of advanced technology. The healthcare industry in China, India, Japan, and South Korea dedicates substantial investments to building digital healthcare systems and AI-based medical products.  The increasing middle-class community, together with smartphone penetration and healthcare affordability needs, drives the implementation of AI technology in cardiology across this region. Government programs that back AI development alongside healthcare innovation, such as China's "Healthy China 2030" and India's "Digital Health Mission," boost market expansion. AI-based diagnostic and predictive solutions for local healthcare needs are developed through partnerships between domestic startup firms and international corporations.

Key Artificial Intelligence in Cardiology Companies:

The following are the leading companies in the artificial intelligence in cardiology market. These companies collectively hold the largest market share and dictate industry trends.

• IDOVEN
• Cleerly, Inc.
• Ultrasight
• CardiAI
• RSIP Vision
• DiA Imaging Analysis (Koninklijke Philips N.V.)
• Ultromics Limited
• Arterys Inc. (Tempus)
• Vista AI
• Viz AI
• Cardiologs (Koninklijke Philips N.V.)
• Medical AI Co., Ltd.
• Others

Recent Developments

• In May 2025, Anumana extended its AI platform to include acute cardiac care and perioperative care, in addition to diagnostic ECG-AI technology, to cover full cardiovascular care.  The business is creating generative AI visualization and imaging tools to improve the results for cardiac patients.
• In March 2025, Us2.AI and Fujifilm collaborated to automate echocardiograms using AI.  This partnership enables completely automated evaluations of heart chambers by fusing Fujifilm's LISENDO 800 Ultrasound System with Us2.AI's AI-driven analysis.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the artificial intelligence in cardiology market based on the below-mentioned segments:  

Global Artificial Intelligence In Cardiology Market, By Component

• Software
• Hardware
• Services

Global Artificial Intelligence In Cardiology Market, By Application

• Diagnosis
• Prediction
• Drug Discovery
• Others

Global Artificial Intelligence In Cardiology Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa